Showing results (91-100 of 179) with videos related to
Sort By:
Pageof 18
Clinical Hematology International|October 1, 2021
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic LeukemiaEnrico Maffini, Francesco Saraceni, Francesco LanzaClinical Hematology International|October 1, 2021
Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell TransplantationJuliana Matthews, Dwight Eplin, Bipin Savani, et al.Clinical Hematology International|October 1, 2021
Moving Toward Continuous Therapy in Multiple MyelomaFrancesca Bonello, Giusy Cetani, Luca Bertamini, et al.Clinical Hematology International|October 1, 2021
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World StudyAgoston Gyula Szabo, Katrine Fladeland Iversen, Sören Möller, et al.Clinical Hematology International|October 1, 2021
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell TransplantationDwight D Eplin, Anna D Jackson, Austin M Smith, et al.Clinical Hematology International|October 1, 2021
Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell TransplantationAbraham S Kanate, Arnon Nagler, Bipin SavaniClinical Hematology International|October 1, 2021
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple MyelomaSarah A Bird, Graham H Jackson, Charlotte PawlynClinical Hematology International|October 1, 2021
Repeat Endoscopy Affects Patient Management in Gastrointestinal Graft-Versus-Host DiseaseEhsan Shabbir, Umar Farooq, Burhan Yanes, et al.Clinical Hematology International|October 1, 2021
Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor TransplantationRaheel Iftikhar, Qamar Un Nisa Chaudhry, Tariq Mehmood Satti, et al.Clinical Hematology International|October 1, 2021
Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2)Uttam K Rao, Brian G EngelhardtPageof 18